In cases of advanced prostate cancer, the correct radiation dose is crucial. Researchers in Dresden have developed a method that combines two diagnostic procedures into a single molecule. This makes it possible to tailor treatment precisely to the patient.
Researchers in Dresden have discovered a protein in the blood that reveals how aggressive a prostate tumor is. Following further tests, MMP11 could be used as a simple blood test in the future and make cancer therapy more targeted.
| more
